← Back to headlines
AstraZeneca Sees GLP-1 Market Beyond Weight Loss
AstraZeneca states that the market for GLP-1 drugs extends beyond just weight loss, indicating potential for these medications in treating other conditions.
15 Aug, 12:25 — 15 Aug, 12:25
Sources
Showing 1 of 1 sources



